New Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis

Cushing, 1932, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism), Bull Johns Hopkins Hosp, 50, 137

Reid, 1998, Glucocorticoid-induced osteoporosis, J Clin Densitometry, 1, 65, 10.1385/JCD:1:1:65

Mankin, 1992, Nontraumatic necrosis of bone (osteonecrosis), N Engl J Med, 325, 1473

Parfitt, 1994, Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone, J Cell Biochem, 55, 273, 10.1002/jcb.240550303

Manolagas, 1995, Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506

Abe, 1998, Requirement of BMPs2/4 for postnatal osteoblast and osteoclast formation: Antagonism by noggin, Bone, 23, S242

Ducy, 1997, Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation, Cell, 89, 747, 10.1016/S0092-8674(00)80257-3

Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X

O'Brien, 1998, Identification of an OSF-2 binding site in the murine RANKL/OPGL gene promoter: A potential link between osteoblastogenesis and osteoclastogenesis, Bone, 23, S149

Hughes, 1996, Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β, Nat Med, 2, 1132, 10.1038/nm1096-1132

Jilka, 1998, Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines, J Bone Miner Res, 13, 793, 10.1359/jbmr.1998.13.5.793

Parfitt, 1990, The osteoblast and osteoclast, Bone, 1, 351

Jilka, 1992, Increased osteoclast development after estrogen loss: Mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100

Jilka, 1996, Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence, J Clin Invest, 97, 1732, 10.1172/JCI118600

Fitzpatrick, 1994, Osteoporosis, 202

Dempster, 1989, A prospective: Bone histomorphometry in glucocorticoid-induced osteoporosis, J Bone Miner Res, 4, 137, 10.1002/jbmr.5650040202

Paz-Pacheo, 1995, Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects, J Bone Miner Res, 10, 1713, 10.1002/jbmr.5650101114

Pearce, 1998, Corticosteroid-induced bone loss in men, J Clin Endocrinol Metab, 83, 801, 10.1210/jcem.83.3.4621

Hahn, 1981, Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man, J Clin Endocrinol Metab, 52, 111, 10.1210/jcem-52-1-111

Weinstein, 1998, Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteoclasts by glucocorticoids: Potential mechanisms of their deleterious effects on bone, J Clin Invest, 102, 274, 10.1172/JCI2799

Bellido, 1998, Overexpression of Bcl-2 renders osteoblastic cells refractory to glucocorticoid-induced apoptosis, Bone, 23, S324

Weinstein, 1998, Anatomic juxtaposition of apoptotic osteoclasts and avascular necrosis in femurs from patients with glucocorticoid-excess, Bone, 23, S461

Tomkinson, 1997, The death of osteoclasts via apoptosis accompanies oestrogen withdrawal in human bone, J Clin Endocrinol Metab, 82, 3128

Frost, 1960, In vivo osteocyte death, J Bone Joint Surg, 42A, 138, 10.2106/00004623-196042010-00011

Chang, 1998, Reduction in transforming growth factor beta receptor I expression and transcription factor Cbfa1 on bone cells by glucocorticoid, J Biol Chem, 273, 4892, 10.1074/jbc.273.9.4892

Centrella, 1997, Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures, J Cell Biochem, 67, 528, 10.1002/(SICI)1097-4644(19971215)67:4<528::AID-JCB10>3.0.CO;2-5

Canalis, 1998, Inhibitory actions of glucocorticoids on skeleton growth: Is local insulin-like growth factor I to blame?, Endocrinology, 139, 3041, 10.1210/endo.139.7.6169

Shi, 1998, Glucocorticoids induce adipogenesis of stromal cells by transcriptionally activating PPARγ2, Bone, 23, S454

Lecka-Czernik, 1999, Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma 2, J Cell Biochem, 74, 1, 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7

Adachi, 1997, Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis, N Engl J Med, 337, 382, 10.1056/NEJM199708073370603

Reid, 1997, Preventing glucocorticoid-induced osteoporosis, N Engl J Med, 337, 420, 10.1056/NEJM199708073370609

Saag, 1998, Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis, N Engl J Med, 339, 292, 10.1056/NEJM199807303390502

Plotkin, 1998, Bisphosphonates prevent glucocorticoid-induced apoptosis of osteocytes in vitro: A putative mechanism influencing mechanosensing, Bone, 23, S157

Lane, 1998, Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis, J Clin Invest, 102, 1627, 10.1172/JCI3914

Jilka, 1998, PTH increases bone formation by postponing osteoblast apoptosis, not by increasing precursor proliferation, Bone, 23, S519

Bellido, 1998, PTH prevents glucocorticoid-induced apoptosis of osteoblasts and osteoclasts in vitro: Direct interference with a private death pathway upstream from caspase-3, Bone, 23, S518

Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6

Vayssiere, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo, Mol Endocrinol, 11, 1245, 10.1210/mend.11.9.9979